{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:00Z","timestamp":1787041680157,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304382"],"award-info":[{"award-number":["82304382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2408085Y045"],"award-info":[{"award-number":["2408085Y045"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119065","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:22:46Z","timestamp":1781763766000},"page":"119065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A PROTAC-inspired bifunctional small molecule recruits CDK6 to target EYA2 degradation and suppress breast tumor growth"],"prefix":"10.1016","volume":"317","author":[{"given":"Yanhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-2530","authenticated-orcid":false,"given":"Qichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119065_bib1","doi-asserted-by":"crossref","first-page":"e2928","DOI":"10.1038\/cddis.2017.325","article-title":"The EGFR\/miR-338-3p\/EYA2 axis controls breast tumor growth and lung metastasis","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119065_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/0008-5472.925.65.3","article-title":"Transcriptional coactivator drosophila eyes absent homologue 2 is Up-Regulated in epithelial ovarian cancer and promotes tumor growth","volume":"65","author":"Zhang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119065_bib3","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22860","article-title":"EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.119065_bib4","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1074\/jbc.C900032200","article-title":"Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent","volume":"284","author":"Krishnan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119065_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biocel.2017.09.001","article-title":"The Eya phosphatase: its unique role in cancer","volume":"96","author":"Zhou","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119065_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.biochem.76.052705.164916","article-title":"The eyes absent family of phosphotyrosine phosphatases: properties and roles in developmental regulation of transcription","volume":"76","author":"Jemc","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.119065_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/14728222.2014.978860","article-title":"The SIX1-EYA transcriptional complex as a therapeutic target in cancer","volume":"19","author":"Blevins","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2026.119065_bib8","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-20-0435","article-title":"Identification of a small-molecule inhibitor that disrupts the SIX1\/EYA2 complex, EMT, and metastasis","volume":"80","author":"Zhou","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119065_bib9","article-title":"Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity","volume":"18","author":"Krueger","year":"2012","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2026.119065_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119065_bib11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMe1611926","article-title":"CDK4 and CDK6 inhibition in breast cancer \u2014 a new standard","volume":"375","author":"Wolff","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119065_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41417-024-00747-x","article-title":"Recent progress of CDK4\/6 inhibitors' current practice in breast cancer","volume":"31","author":"Wang","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejmech.2026.119065_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2018.06.008","article-title":"CDK4\/6 inhibitors in breast cancer therapy: current practice and future opportunities","volume":"191","author":"Lynce","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119065_bib14","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3390\/cancers12092480","article-title":"CDK4\/6 inhibitors in hormone receptor-positive metastatic breast cancer: current practice and knowledge","volume":"12","author":"de Melo Gagliato","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119065_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2013.07.012","article-title":"A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis","volume":"24","author":"Kollmann","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119065_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ccr.2013.07.019","article-title":"The Kinase-Independent, second life of CDK6 in transcription","volume":"24","author":"Otto","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119065_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127106","article-title":"Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs","volume":"30","author":"Anderson","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119065_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.str.2015.10.020","article-title":"Structural basis for the non-catalytic functions of protein kinases","volume":"24","author":"Kung","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.119065_bib19","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1021\/acs.jmedchem.1c01978","article-title":"Targeting the non-catalytic functions: a new paradigm for kinase drug discovery?","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119065_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41422-025-01110-x","article-title":"Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1","volume":"35","author":"He","year":"2025","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.119065_bib21","doi-asserted-by":"crossref","first-page":"eadi5798","DOI":"10.1126\/science.adi5798","article-title":"Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1\/3 degrader NX-2127","volume":"383","author":"Montoya","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119065_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4161\/cc.26755","article-title":"CDK6 binds and promotes the degradation of the EYA2 protein","volume":"13","author":"Kohrt","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2026.119065_bib23","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/onc.2010.122","article-title":"The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells","volume":"29","author":"Pandey","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.119065_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature07849","article-title":"Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions","volume":"458","author":"Cook","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119065_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbpa.2019.11.012","article-title":"Targeted protein degradation: current and future challenges","volume":"56","author":"Hanzl","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119065_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-Targeting chimeras as therapeutics and tools for biological discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119065_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.chembiol.2021.04.011","article-title":"Targeted protein degradation: a promise for undruggable proteins","volume":"28","author":"Samarasinghe","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119065_bib28","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/s41467-023-42233-2","article-title":"Expanding PROTACtable genome universe of E3 ligases","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119065_bib29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.chembiol.2021.04.002","article-title":"An E3 ligase guide to the galaxy of small-molecule-induced protein degradation","volume":"28","author":"Jevti\u0107","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119065_bib30","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.chembiol.2021.04.007","article-title":"Expanding the arsenal of E3 ubiquitin ligases for proximity-induced protein degradation","volume":"28","author":"Kannt","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119065_bib31","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1021\/acs.jmedchem.9b00871","article-title":"Potent and preferential degradation of CDK6 via proteolysis targeting chimera degraders","volume":"62","author":"Su","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119065_bib32","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1039\/D0SC00167H","article-title":"Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders","volume":"11","author":"Steinebach","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119065_bib33","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.2019003604","article-title":"Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs","volume":"135","author":"De Dominici","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119065_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/genes12091355","article-title":"Targeting the CDK6 dependence of Ph+ Acute lymphoblastic leukemia","volume":"12","author":"Porazzi","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ejmech.2026.119065_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118282","article-title":"10PL8 and 2fPL8 inhibit gastric cancer cell proliferation by targeting degradation of CDK6 proteins to arrest the cell cycle","volume":"128","author":"Zhang","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119065_bib36","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119065_bib37","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119065_bib38","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:17Z","timestamp":1787040257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S0223523426005106"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119065","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A PROTAC-inspired bifunctional small molecule recruits CDK6 to target EYA2 degradation and suppress breast tumor growth","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119065"}}